These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5351861)

  • 1. Urinary metabolites of 10-(3'-(4"-methyl-piperazinyl)-propyl)-phenothiazine (perazine) in psychiatric patients. II. Individual metabolite patterns and their changes in the course of treatment.
    Kanig K; Breyer U
    Psychopharmacologia; 1969; 14(3):211-20. PubMed ID: 5351861
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a urinary metabolite of perazine as a piperazine-2,5-dione derivative.
    Krauss D; Otting W; Breyer U
    J Pharm Pharmacol; 1969 Dec; 21(12):808-13. PubMed ID: 4391052
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary metabolites of 10-[3'-(4"-methylpiperazinyl)-propyl]-phenothiazine (perazine) in psychiatric patients. I. Isolation, identification and determination of metabolites.
    Breyer U
    Biochem Pharmacol; 1969 Apr; 18(4):777-88. PubMed ID: 5788518
    [No Abstract]   [Full Text] [Related]  

  • 4. Piperacetazine in chronic mental patients: clinical observations and new urine color test.
    Forrest FM; Forrest IS
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):689-95. PubMed ID: 4629106
    [No Abstract]   [Full Text] [Related]  

  • 5. [ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].
    Welbel L; Zalewski K
    Psychiatr Pol; 1971; 5(1):49-54. PubMed ID: 5551991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longitudinal studies on the metabolite pattern of perazine and related phenothiazines in human and animal].
    Breyer U
    Arzneimittelforschung; 1974 Jul; 24(7):989-90. PubMed ID: 4152695
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible mutagenicity of the psychoactive phenothiazine derivative perazine in vivo and in vitro.
    Madle S; Obe G; Schroeter H; Herha J; Pietzcker A
    Hum Genet; 1980; 53(3):357-61. PubMed ID: 6102962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiochromatographic studies of excretion and metabolism of methophenazine (Frenolon) in animal experiments].
    Jászsági-Nagy E; Elekes I
    Pharmazie; 1969 Jun; 24(6):337-8. PubMed ID: 5807396
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenothiazines: metabolism and analytical detection.
    Forrest IS; Green DE
    J Forensic Sci; 1972 Oct; 17(4):592-617. PubMed ID: 4680760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the therapeutic effect of Vesitan].
    Cwiertnia T
    Psychiatr Pol; 1968; 2(6):639-44. PubMed ID: 5730288
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of excreted substances in the urine of man and dogs after administration of dimethylsulfamido-3-(dimethylamino-2-propyl)-10-phenothiazine (dimethithiazine)].
    Jolles G; Julou L; Terlain B
    Arch Int Pharmacodyn Ther; 1968 Feb; 171(2):449-61. PubMed ID: 5725157
    [No Abstract]   [Full Text] [Related]  

  • 12. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 14. [Principles of a differentiated treatment of schizophrenia using psychotropic agents].
    Awruzkij GJ
    Psychiatr Neurol Med Psychol (Leipz); 1966 Dec; 18(12):459-61. PubMed ID: 5983906
    [No Abstract]   [Full Text] [Related]  

  • 15. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia.
    Gaebel W; Müller-Oerlinghausen B; Schley J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):891-900. PubMed ID: 1355303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of chlorpromazine metabolites in urine.
    Turner WJ; Turano PA; March JE
    Clin Chem; 1970 Nov; 16(11):916-21. PubMed ID: 5473553
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 19. Pigmentation and the chemcial basis of schizophrenia.
    Patch IC
    Acta Psychiatr Scand; 1975 Jun; 51(5):312-8. PubMed ID: 1146590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
    Schooler NR; Boothe H; Goldberg SC
    Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.